CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2019—Abbott announced it has received the CE mark for its Alinity m automated molecular diagnostics system and assays.
Alinity m features ReadiFlex technology, the company’s proprietary technology for true random access, a universal sample rack, and a time to first result of less than 115 minutes. The system can provide 300 results in about eight hours and can have up to 20 assays onboard at one time. Alinity m may also reduce the lab equipment footprint of four to six instruments down to one, the company reports.
Alinity m STI assays include virologic testing for HIV 1, hepatitis B virus, and hepatitis C virus; sexual health-related testing for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium, or CT/NG/TV/MG panel; and high-risk human papillomavirus testing.